A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer

Journal of Leukocyte Biology

Volumn 91, Issue 4, 2012, Pages 591-598

  Dumitru, Claudia A ^a   Fechner, Maren K ^a   Hoffmann, Thomas K ^a   Lang, Stephan ^a   Brandau, Sven ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

CCL4; CREB; Inflammation; MMP9; P27

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GELATINASE B; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P27;

ARTICLE; CELL FUNCTION; CELL STRAIN HL 60; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; NEUTROPHIL; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL MOVEMENT; CELL SURVIVAL; CHEMOKINE CCL4; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; HEAD AND NECK NEOPLASMS; HL-60 CELLS; HUMANS; INTERLEUKIN-8; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NEOPLASM PROTEINS; NEUTROPHIL INFILTRATION; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84860878037     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0411193     Document Type: Article

References (28)

1. Coussens, L. M., Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
2. Lin, W. W., Karin, M. (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183.
3. Schmidt, H., Suciu, S., Punt, C. J., Gore, M., Kruit, W., Patel, P., Lienard, D., von der Maase, H., Eggermont, A. M., Keilholz, U., American Joint Committee on Cancer Stage IV Melanoma, EORTC 18951 (2007) Pre-treatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemo-therapy Trial. J. Clin. Oncol. 25, 1562-1569.
4. Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., von der Maase, H. (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol. 27, 4709-4717.
5. Kuang, D. M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X. Y., Zheng, L. (2011) Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol. 54, 948-955.
6. Schmielau, J., Finn, O. J. (2001) Activated granulocytes and granulo-cyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res. 61, 4756-4760.
7. Goddard, D. S., Yamanaka, K., Kupper, T. S., Jones, D. A. (2005) Activation of neutrophils in cutaneous T-cell lymphoma. Clin. Cancer Res. 11, 8243-8249.
8. Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bank-falvi, A., Scherag, A., Hutte, J., Dominas, N., Lehnerdt, G. F., Hoffmann, T. K., Lang, S., Brandau, S. (2011) Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int. J. Cancer 129, 2183-2193.
9. Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., Bankfalvi, A., Whiteside, T. L., Lang, S., Brandau, S. (2011) Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int. J. Cancer 129, 859-869.
10. Kyriakis, J. M., Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869.
11. Qian, F., Deng, J., Cheng, N., Welch, E. J., Zhang, Y., Malik, A. B., Flavell, R. A., Dong, C., Ye, R. D. (2009) A non-redundant role for MKP5 in limiting ROS production and preventing LPS-induced vascular injury. EMBO J. 28, 2896-2907.
12. Heit, B., Robbins, S. M., Downey, C. M., Guan, Z., Colarusso, P., Miller, B. J., Jirik, F. R., Kubes, P. (2008) PTEN functions to "prioritize" chemot-actic cues and prevent "distraction" in migrating neutrophils. Nat. Immunol. 9, 743-752.
13. Hidalgo, A., Peired, A. J., Wild, M. K., Vestweber, D., Frenette, P. S. (2007) Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 26, 477-489.
14. Hoffmann, T. K., Sonkoly, E., Hauser, U., van Lierop, A., Whiteside, T. L., Klussmann, J. P., Hafner, D., Schuler, P., Friebe-Hoffmann, U., Scheckenbach, K., Erjala, K., Grenman, R., Schipper, J., Bier, H., Balz, V. (2008) Alterations in the p53 pathway and their association with radio-and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 44, 1100-1109.
15. Vermeulen, L., Vanden Berghe, W., Beck, I. M., De Bosscher, K., Haege-man, G. (2009) The versatile role of MSKs in transcriptional regulation. Trends Biochem. Sci. 34, 311-318.
16. Motti, M. L., De Marco, C., Califano, D., Fusco, A., Viglietto, G. (2004) Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer. Cell Cycle 3, 1074-1080.
17. Fujita, N., Sato, S., Tsuruo, T. (2003) Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 278, 49254-49260.
18. Pan, C., Olsen, J. V., Daub, H., Mann, M. (2009) Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphopro-teomics. Mol. Cell. Proteomics. 8, 2796-2808.
19. Davies, S. P., Reddy, H., Caivano, M., Cohen, P. (2000) Specificity and mechanisms of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
20. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., Gallo, R. C. (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75, 2458-2462.
21. Klausen, P., Bjerregaard, M. D., Borregaard, N., Cowland, J. B. (2004) End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6. J. Leukoc. Biol. 75, 569-578.
22. Larrea, M. D., Hong, F., Wander, S. A., da Silva, T. G., Helfman, D., Lan-nigan, D., Smith, J. A., Slingerland, J. M. (2009) RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc. Natl. Acad. Sci. USA 106, 9268-9273.
23. Liang, J., Shao, S. H., Xu, Z. X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., Slingerland, J. M., Mills, G. B. (2007) The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter au-tophagy or apoptosis. Nat. Cell Biol. 9, 218-224.
24. Erreni, M., Bianchi, P., Laghi, L., Mirolo, M., Fabbri, M., Locati, M., Mantovani, A., Allavena, P. (2009) Expression of chemokines and chemokine receptors in human colon Cancer Methods Enzymol. 460, 105-121.
25. Saito, S., Kitayama, J., Jin, Z. X., Tsuno, N., Kaisaki, S., Seto, Y., Nagawa, H. (2003) β-Chemokine, macrophage inflammatory protein-1β (MIP-1β), is highly expressed in diffuse type human gastric cancers. J. Exp. Clin. Cancer Res. 22, 453-459.
26. Blum, D. L., Koyama, T., M'Koma, A. E., Iturregui, J. M., Martinez-Ferrer, M., Uwamariya, C, Smith, J. A, Clark, P. E., Bhowmick, N. A. (2008) Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy. Clin. Cancer Res. 14, 7790-7797.
27. Chang, C, Werb, Z. (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11, S37-S43.
28. Stefanidakis, M., Koivunen, E. (2006) Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 108, 1441-1450.